WHO Launches COVID-19 Technology Access Pool
IGBA Supports C-TAP, Which Encourages Sharing IP And Data
C-TAP, the voluntary initiative aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all, has been launched by the WHO, in partnership with Costa Rica.
You may also be interested in...
The WHO and Medicines Patent Pool have announced “the first transparent, global, non-exclusive license for a COVID-19 technology” after striking a deal for a COVID-19 serological antibody technology with the Spanish National Research Council through the WHO’s COVID-19 Technology Access Pool.
The Medicines Patent Pool and the International Generic and Biosimilar medicines Association have announced separate initiatives with the continued intention to facilitate access to COVID-19 treatments and vaccines, as the global threat from the novel coronavirus pandemic continues.
Also, Neoimmune looks to interleukin therapy for mild therapy while Daiichi Sankyo bets on a mRNA vaccine.